DP World achieves 65% renewable energy use in 2024, paving way for sustainable healthcare logistics
DP World’s latest sustainability report highlights its investment in green infrastructure and sustainable finance, supporting…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Zydus Lifesciences to Acquire 85.6% of Amplitude Surgical, block acquisition expected by Q3 2025
Zydus signs share purchase agreement to acquire majority stake in Amplitude Surgical, subject to regulatory approval and closing…
Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL
European Medicines Agency’s CHMP recommends approval of Biocon Biologics' denosumab biosimilars for bone health indications
Sun Pharma must immediately declare a voluntary recall of Levipil 500
Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…
ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…
Building a pharma-ready logistics network: The need for compliance, speed, and scalability
In the article, Nitesh Agarwal, President of CJ Darcl Logistics, outlines the critical infrastructure, regulatory, and…
Morepen Laboratories expands its domestic portfolio
The company strengthens its finished dosages business with new products across cardiology, hepatology, nutrition, and…
Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine
ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions
Avery Dennison opens first RFID inlay and label production facility in India
Pune facility marks company's expansion under 'Make in India' initiative, enabling local RFID manufacturing and supply chain…
Lupin receives US FDA approval for generic Tolvaptan Tablets
Company secures 180-day marketing exclusivity as first-to-file applicant for bioequivalent to Jynarque
Oxford Nanopore and BRIC Institutes sign Letters of Intent to establish two Centres of Excellence in…
Collaborations with BRIC-CDFD and BRIC-NIBMG to support rare disease, cancer, and infectious disease research using Oxford…
India advances indigenous HPV screening kits for cervical cancer through DBT-BIRAC partnership
Department of Biotechnology-led initiative under review; Minister Jitendra Singh highlights public-private collaboration and…
Sun Pharma and Moebius Medical publish clinical and mechanistic data on non-opioid knee…
Phase 2b study and supporting research highlight MM-II’s potential in symptomatic knee osteoarthritis; new findings presented at…
Pharma and healthcare deals in Q1 2025 remain stable amid shift to scalable global models
Grant Thornton Bharat reports 71 transactions totalling USD 2.6 billion in Q1 2025, with investor activity focused on mid-market…
DHL Express and Sai Life Sciences partner to cut emissions in pharma logistics with GoGreen Plus
Sai Life Sciences adopts DHL’s GoGreen Plus service to reduce greenhouse gas emissions by 90 per cent using sustainable aviation…
PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety
Chakravarthi AVPS delivers special address on drug safety and moderates key discussion at PHARMAP 2025, shaping the future of…
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals…
GlobalData survey uncovers stark regional differences in physician support for patient involvement in choosing between biologics…
PADCEV™ (enfortumab vedotin) now available in India for locally advanced or metastatic urothelial…
Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease…
On the occasion of World Liver Day, Jayashree Aiyar, Chief Scientific Officer, Syngene International shared her insights into a…